N. Sato et al., Enhancement of drug-induced apoptosis by anti sense oligodeoxynucleotides targeted against Mdm2 and p21(WAF1/CIP1), ANTICANC R, 20(2A), 2000, pp. 837-842
The p53 tumor suppressor gene plays an important role in DNA damage-induced
apoptosis and, in general, inactivation of p53 contributes to pool respons
e to chemotherapy. Apoptotic activity of p53 may be negatively modulated by
expression of its downstream mediators, including Mdm2 and p21(WAF1/CIP1).
Consequently, these cellular pathways Mdm2 and p21 also represent potentia
l targets for cancer therapy. This study investigated the effect of antisen
se oligodeoxynucleotides (ODNs), targeted against Mdm2 and p21 on drug-medi
ated cell killing. Exposure of U2-OS osteosarcoma cells to DNA damaging age
nts, cisplatin or mitomycin C, caused up regulated expression of Mdm2 and p
21 Transient transfection of cells with antisense ODNs to Mdm2 mRNA inhibit
ed Mdm2 protein expression and markedly enhanced apoptotic cell death induc
ed by these drugs. Moreover, when p21(WAF1/CIP1) expression was blacked by
antisense transfection, drug-mediated cell killing was further accelerated.
These results suggest that the inhanced expression of Mdm2 and p21(WAF1/CI
P1) may inhibit p53-mediated apoptosis and I ender p21 cells resistant to t
he effects of DNA damaging agents. Consequently, antisense ODNs targeted ag
ainst Mdm2 and p21(WAF1/CIP1) could be employed in a potential therapeutic
strategy sensitizing armor cells to cel tain antineoplastic agents.